1. Home
  2. BDSX vs MATH Comparison

BDSX vs MATH Comparison

Compare BDSX & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • MATH
  • Stock Information
  • Founded
  • BDSX 2005
  • MATH 2015
  • Country
  • BDSX United States
  • MATH Hong Kong
  • Employees
  • BDSX N/A
  • MATH N/A
  • Industry
  • BDSX Precision Instruments
  • MATH Finance/Investors Services
  • Sector
  • BDSX Health Care
  • MATH Finance
  • Exchange
  • BDSX Nasdaq
  • MATH Nasdaq
  • Market Cap
  • BDSX 53.2M
  • MATH 60.8M
  • IPO Year
  • BDSX 2020
  • MATH N/A
  • Fundamental
  • Price
  • BDSX $0.41
  • MATH $2.84
  • Analyst Decision
  • BDSX Strong Buy
  • MATH
  • Analyst Count
  • BDSX 5
  • MATH 0
  • Target Price
  • BDSX $1.75
  • MATH N/A
  • AVG Volume (30 Days)
  • BDSX 1.4M
  • MATH 213.8K
  • Earning Date
  • BDSX 08-07-2025
  • MATH 07-30-2025
  • Dividend Yield
  • BDSX N/A
  • MATH N/A
  • EPS Growth
  • BDSX N/A
  • MATH N/A
  • EPS
  • BDSX N/A
  • MATH 0.41
  • Revenue
  • BDSX $76,556,000.00
  • MATH $44,567,257.00
  • Revenue This Year
  • BDSX $17.29
  • MATH N/A
  • Revenue Next Year
  • BDSX $29.33
  • MATH N/A
  • P/E Ratio
  • BDSX N/A
  • MATH $6.83
  • Revenue Growth
  • BDSX 25.70
  • MATH 165.86
  • 52 Week Low
  • BDSX $0.17
  • MATH $0.80
  • 52 Week High
  • BDSX $2.04
  • MATH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 53.27
  • MATH 43.36
  • Support Level
  • BDSX $0.37
  • MATH $2.66
  • Resistance Level
  • BDSX $0.43
  • MATH $3.13
  • Average True Range (ATR)
  • BDSX 0.04
  • MATH 0.29
  • MACD
  • BDSX -0.00
  • MATH -0.03
  • Stochastic Oscillator
  • BDSX 48.25
  • MATH 12.89

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

Share on Social Networks: